Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
GSK843 is an inhibitor of receptor-interacting serine/threonine kinase 3 (RIPK3; IC50 = 6.5 nM).1 It is selective for RIPK3 over a panel of 300 additional kinases at 1 µM. GSK843 (10 µM) induces apoptosis in L-929 fibroblasts. It inhibits TNF-α-induced necroptosis in primary human neutrophils in a concentration-dependent manner. GSK843 (3 µM) also inhibits necrosis induced by the toll-like receptor 3 (TLR3) agonist poly (I:C) in IFN-β-primed 3T3-SA fibroblasts.2 Intrathecal administration of GSK843 (5 µl of a 13 mM solution) increases the paw withdrawal threshold and latency in a mouse model of inflammatory pain induced by complete Freund’s adjuvant.3
WARNING This product is not for human or veterinary use.
1. RIP3 induces apoptosis independent of pronecrotic kinase activity. Mol. Cell 56(4), 481-495 (2014).
2. Toll-
3. Role of spinal RIP3 in inflammatory pain and electroacupuncture-